Atrion Corporation Announces CFO Succession Plan
26 August 2022 - 7:35AM
Atrion Corporation. (NASDAQ: ATRI) today announced that its Board
of Directors has approved a succession plan under which Cindy
Ferguson, currently the Company’s Controller, will become the
Company’s Vice President and Chief Financial Officer, Secretary,
and Treasurer effective March 4, 2023, succeeding Jeffery
Strickland, who currently holds those positions and whose
retirement effective March 3, 2023 has been previously reported.
Emile A Battat, Chairman of the Board, stated, “Mr. Strickland
joined the Company in 1983 and has served in his current positions
since 1997. Throughout his almost 40 years of service to the
Company, Mr. Strickland has worked tirelessly to create a stronger
company, and we are indebted to him for his commitment, insight,
and integrity.” Mr. Battat added, “The Company is pleased to
announce an orderly succession by naming Ms. Ferguson to succeed
Mr. Strickland as Vice President and Chief Financial Officer,
Secretary, and Treasurer well in advance of his retirement. We look
forward to working with her for many more years.”
Ms. Ferguson joined the Company on June 14, 2021 as our
Controller and has served in that position since that date. Prior
to joining the Company, Ms. Ferguson spent 17 years with Texas
Instruments in various accounting and finance roles both
domestically and in Europe. Ms. Ferguson graduated with a Bachelor
of Business Administration degree in Accounting from Texas Tech
University.
“I’m looking forward to the opportunity to be involved in the
Company’s future successes in my next role,” Ms. Ferguson said. She
added, “Mr. Strickland and I have an excellent working relationship
and will continue to work together until his retirement to ensure
this transition is smooth and successful.”
Atrion Corporation develops and manufactures products
primarily for medical applications. The Company’s website is
www.atrioncorp.com.
Statements in this press release that are forward looking are
based upon current expectations and actual results or future events
may differ materially. Such statements include, but are
not limited to, the Company’s expectations regarding the Company’s
succession plan. Words such as “expects,” “believes,”
“anticipates,” “forecasts,” “intends,” “should”, “plans,” “will”
and variations of such words and similar expressions are intended
to identify such forward-looking statements. Forward-looking
statements contained herein involve numerous risks and
uncertainties, and there are a number of factors that could cause
actual results or future events to differ materially, including,
but not limited to, the following: the risk that the COVID-19
pandemic continues to lead to material delays and cancellations of,
or reduced demand for, procedures in which our products are
utilized; curtailed or delayed capital spending by hospitals and
other healthcare providers; disruption to our supply chain;
closures of our facilities; delays in training; delays in gathering
clinical evidence; diversion of management and other resources to
respond to the COVID-19 outbreak; the impact of global and regional
economic and credit market conditions on healthcare spending; the
risk that the COVID-19 virus continues to disrupt local economies
and to cause economies in our key markets to enter prolonged
recessions; changing economic, market and business conditions; acts
of war or terrorism; the effects of governmental regulation; the
impact of competition and new technologies; slower-than-anticipated
introduction of new products or implementation of marketing
strategies; implementation of new manufacturing processes or
implementation of new information systems; our ability to protect
our intellectual property; changes in the prices of raw materials;
changes in product mix; intellectual property and product liability
claims and product recalls; the ability to attract and retain
qualified personnel; and the loss of, or any material reduction in
sales to, any significant customers. In addition,
assumptions relating to budgeting, marketing, product
development and other management decisions are subjective in many
respects and thus susceptible to interpretations and periodic
review which may cause us to alter our marketing, capital
expenditures or other budgets, which in turn may affect our results
of operations and financial condition. The foregoing list of
factors is not exclusive, and other factors are set forth in the
Company’s filings with the Securities and Exchange Commission. The
forward-looking statements in this press release are made as of the
date hereof, and we do not undertake any obligation, and disclaim
any duty, to supplement, update or revise such statements, whether
as a result of subsequent events, changed expectations or
otherwise, except as required by applicable law.
Contact: |
Jeffery Strickland |
|
Vice President and Chief Financial
Officer |
|
(972) 390-9800 |
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ATRION (NASDAQ:ATRI)
Historical Stock Chart
From Apr 2023 to Apr 2024